share_log

科濟藥業-B：截至2024年1月31日止月份之股份發行人的證券變動月報表

CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 6 06:32
Summary by Moomoo AI
科濟藥業-B（02171.HK）於2024年2月6日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底結存及本月底結存均為200,000,000,000股，每股面值0.00000025美元，法定/註冊股本總額為50,000美元。根據2019年股權激勵計劃及2021年首次公開發售後受限制股份單位計劃，本月內發行的新股份數目為1,942股，而本月底可能發行的新股份數目為3,800,444股。該報告亦確認，所有證券發行均已獲得董事會授權，並符合相關法律規定。
科濟藥業-B（02171.HK）於2024年2月6日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底結存及本月底結存均為200,000,000,000股，每股面值0.00000025美元，法定/註冊股本總額為50,000美元。根據2019年股權激勵計劃及2021年首次公開發售後受限制股份單位計劃，本月內發行的新股份數目為1,942股，而本月底可能發行的新股份數目為3,800,444股。該報告亦確認，所有證券發行均已獲得董事會授權，並符合相關法律規定。
KOCHI PHARMACEUTICAL-B (02171.HK) FILED ITS SECURITIES MONTHLY CHANGE REPORT FOR THE YEAR ENDED JANUARY 31, 2024 WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 6, 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 200,000,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0000000025 per share and a total regulated/registered share capital of $50,000. Under the Equity Incentive Plan 2019 and the Restricted Share Unit Plan after the Initial Public Offering in 2021, the number of new shares issued during the month is 1,942 shares and the number of new shares that may be issued at the end of this month is 3,800,444 shares. The report also confirms that all securities issuance has been authorized by the Board of Directors and complies with relevant legal requirements.
KOCHI PHARMACEUTICAL-B (02171.HK) FILED ITS SECURITIES MONTHLY CHANGE REPORT FOR THE YEAR ENDED JANUARY 31, 2024 WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 6, 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 200,000,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0000000025 per share and a total regulated/registered share capital of $50,000. Under the Equity Incentive Plan 2019 and the Restricted Share Unit Plan after the Initial Public Offering in 2021, the number of new shares issued during the month is 1,942 shares and the number of new shares that may be issued at the end of this month is 3,800,444 shares. The report also confirms that all securities issuance has been authorized by the Board of Directors and complies with relevant legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more